HSBC analyst Nicolas Cote-Colisson downgrades Meta Platforms (NASDAQ:META) from Hold to Reduce and announces $110 price target.
GBB Drink Lab. Inc Announce That A Federal Court Has Refused To Dismiss The Company’s Ongoing Lawsuit Against FSD Pharma
GBB Drink Lab. Inc ("GBB" or the "Company"), a maker of the world's first rapid blood alcohol detoxification beverage, is pleased to announce that a federal court has refused to dismiss the Company's ongoing lawsuit
